Emily R. Carrier, MD, is a senior adviser at Manatt, a legal and consulting firm. A medical professional and health care consultant specializing in emergency med ...

Recent changes to Medicare physician payment will lead to near-term payment increases for ‘cognitive services’ such as those delivered by primary care providers and relative decreases for ‘procedural ...

Health Affairs' Rob Lott interviews Dr. Ezekiel Emanuel about his new book, Eat Your Ice Cream: Six Simple Rules for a Long ...

Michael E. Chernew, PhD, is the Leonard D. Schaeffer Professor of Health Care Policy and the director of the Healthcare Markets and Regulation Lab in the Department of Health Care Policy at Harvard ...

More can, and should, be done to improve the transparency and integrity of how local governments help fund Medicaid, but it’s ...

Consider the case of patient WB, a 79-year-old male with recurrent diffuse large B cell lymphoma. He was referred for ...

William D. J. Roberts, MBA, MSc is a Commonwealth Fund Harkness Fellow and a Research Fellow at both the Harvard T.H. Chan School of Public Health and Brown ...

CMMI has spent more than a decade learning which organizations consistently deliver high-value care. The next step is to let ...

The surge in vaccine litigation is not simply a post-pandemic, temporary issue. It is a deeper erosion of the legal principles that have long supported public health authority.

CMS and states should look beyond simply expanding disclosure and improving standardization to also elevate antitrust safeguards.

The emergence of Lilly’s bundling strategy for Zepbound and Taltz reflects the unregulated state of patient assistance programs in the commercial market and the need for Congressional intervention.

In postacute care, we have built a quality architecture that treats falls as actionable events and functional decline as expected aging. The resulting safety-without-recovery trade-off is not a ...